emanuel_asante Profile Banner
Emmanuel C. Asante Profile
Emmanuel C. Asante

@emanuel_asante

Followers
458
Following
1K
Media
5
Statuses
260

PhD candidate in Experimental Medicine @mcgillu

Montréal, Québec
Joined March 2016
Don't wanna be here? Send us removal request.
@PascalFLDI
Pascal Fischer
5 months
The McGill University Department of Oncology and the Lady Davis Institute for Medical Research (@LDI_ILD) in Montreal, Canada, are looking for a full-time Assistant Professor (Research) in the area of Fundamental Cancer Biology. https://t.co/vmaRB8lPT1 #academicstaff #research
ladydavis.ca
Below is the list of research laboratory job opportunities currently available at the LDI. Faculty and other academic positions for researchers at the LDI/McGill University are also featured.
0
2
1
@emanuel_asante
Emmanuel C. Asante
7 months
A huge leap for gene editing therapy
@ChildrensPhila
Children's Hospital
7 months
CHOP & @PennMedicine have delivered the first-ever personalized gene editing therapy for a patient with CPS1 deficiency, marking a major milestone in the application of CRISPR-based treatments. Learn more about KJ & the future of personalized medicine: https://t.co/A9DTcNmxrR.
0
0
2
@emanuel_asante
Emmanuel C. Asante
1 year
Congratulations Dr. @BoluOgunyemi1
@CMA_Docs
Canadian Medical Association
1 year
🗳️The results are in: Dr. @BoluOgunyemi1 has been elected as the CMA president-elect for 2025-26, subject to approval at the 2025 #CMAagm. As Assistant Dean of Social Accountability @MUNMed, Dr. Ogunyemi aims to build a robust & diverse health system. https://t.co/fQEKIflwWK
0
0
2
@emanuel_asante
Emmanuel C. Asante
2 years
💯
0
0
3
@emanuel_asante
Emmanuel C. Asante
2 years
Right….
@GeneInvesting
Gene Investing w/Anthony 🧬
2 years
BREAKING NEWS PRICE SET for $CRSP and $BLUE SCD treatments! $2.2m and $3.1m $VRTX #CRISPR
1
0
3
@emanuel_asante
Emmanuel C. Asante
2 years
A huge win in the hemoglobinopathy space. I hope this therapy will afford and assessable in Africa where sickle cell disease is most prevalent.
@CRISPRTX
CRISPR Therapeutics
2 years
#Breaking: The U.S. FDA approves the CRISPR/Cas9 gene-edited treatment, co-developed with Vertex Pharmaceuticals, for #SickleCellDisease. Learn more: https://t.co/5U9n8WnoV6
0
2
4
@BiotechCH
Biotech Hangout
2 years
On #BiotechHangout today @daphnezohar, @bradloncar, @JMaraganore, @biotech1, @LifeSciVC & @YaronWerber cover $ABBV / $IMGN $10B acquisition, FDA’s CAR-T safety concerns, data setbacks & wins ( $ROIV, $ARGX, $XENE, & $IVMT), $REGN & $SNY seek to expand Dupixent approval to COPD,
39
4
32
@daphnezohar
Daphne Zohar
2 years
Nice report coming out later today from @stifel: “Bullish on Biotech” despite continued negative sentiment. They cite 7 fundamental positives including past performance ($NBI & $XBI tripled following past downturns). Sentiment can turn quickly. @LifeSciVC’s review & #BioTwitter
14
59
285
@CRISPRTX
CRISPR Therapeutics
2 years
The UK Medicines and Healthcare products Regulatory Agency approves the CRISPR/Cas9 gene-edited treatment for #SickleCellDisease & #BetaThalassemia in Great Britain. This is a historic milestone arising out of our collaboration with Vertex. Learn more: https://t.co/XiHsNfOZGA
21
113
437
@BowTiedBiotech
BowTiedBiotech 🧪🔬🧬
2 years
8 REASONS GLP-1 WILL NOT DISPLACE MASH/NASH 1️⃣GLP-1s not the medicine of choice amongst hepatologists 2️⃣10-15% of MASH pts come in on GLP-1s 3️⃣Will use resmetirom if approved in March $MDGL 4️⃣Sarcopenia with GLP-1s is a particular concern for MASH 5️⃣KOLs not comfortable
2
10
32
@BiotechCH
Biotech Hangout
2 years
0
3
2
@emanuel_asante
Emmanuel C. Asante
2 years
Excited to have discussed novel vulnerabilities in melanoma at the Canadian Cancer Research Conference. #CCRC23
7
4
38
@NobelPrize
The Nobel Prize
2 years
BREAKING NEWS The 2023 #NobelPrize in Physiology or Medicine has been awarded to Katalin Karikó and Drew Weissman for their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19.
4K
26K
73K
@BiotechCH
Biotech Hangout
2 years
On #BiotechHangout today @daphnezohar @bradloncar @TimOpler @mpreminger & @BrianSkorney cover latest on $AMGN/ $HZNP and FTC lawsuit, $TSHA financing, $SNY loses $RETA to $BIIB, data & regulatory updates from $SGEN, $PFE, $DCTH, $GLTO & $TSVT, plus $IPSEY gets FDA approval of
2
3
11
@emanuel_asante
Emmanuel C. Asante
3 years
I am at that point in my PhD where I skim through signalling pathways in-between reps at the gym 😂 #phdchat #phdlife #AcademicChatter #AcademicTwitter
2
0
4
@McGillEMGSS
EMGSS
3 years
Reminder that abstracts for the 23rd AMBGC are due next Monday, Feb 13 at 11:59. NEW! A cocktail hour will follow after the conference. Stay with us after the awards ceremony to celebrate your accomplishments with your peers. The cocktail hour is included with free registration
0
1
1
@McGillEMGSS
EMGSS
3 years
Come attend the 2nd Technical Seminar Series of the academic year on Thursday December 15th from 10AM to 11AM! Dr. Ruben Lopez Salazar will be presenting “Lipid-based Nanoparticles: The Small Secret Behind Next-generation Vaccines and their Applications in Cancer Research”.
0
1
3
@McGillEMGSS
EMGSS
3 years
Come attend the 1st Technical Seminar Series of the academic year! This seminar will focus on explaining the fundamentals of flow cytometry, its applications to different research areas, and tips for setting up a successful flow experiment. We look forward to seeing you!
0
2
3
@McGillEMGSS
EMGSS
3 years
We are hosting a free spin class at SpinÉnergie on 3483 Parc Avenue November 18th. Spaces are limited so please sign up asap to secure your spot! Following the class, we will have snacks and drinks from 7:45 to 9:30, we can't wait to see you there🚴‍♂️🎉 https://t.co/hZNi9FswbO
0
1
4
@BiotechCH
Biotech Hangout
3 years
On Friday's #BiotechHangout, @robperez32 joins @DaphneZohar & @JSchimmer_E to discuss the week's deals, data & FDA actions w/ guests @AlexHarding7 & DiCE CEO @KevinJudice. Tell us if there's a topic you'd like us to cover below & tune in at 3pm ET! https://t.co/b1dxyWD2Ta
1
7
37